Abbott says FDA OKs Cholesterol Drug TriLipix

(AP) — Abbott Laboratories said Monday the Food and Drug Administration approved its cholesterol drug TriLipix for sale. TriLipix is part of a class of drugs called fibrates that raise "good" HDL cholesterol while reducing triglycerides and "bad" LDL cholesterol. Abbott said TriLipix, or ...